This hard hat, worn by my OCAW card-carrying grandmother in the Southeast Texas oil refineries, tells the story of where I come from. Thankful this Labor Day for collars that are blue and the Americans who built this nation, one shift at a time.

We talked to nearly 2,400 customers and 94% rated their care experience as equal to or better than in-person care. That’s the power of telehealth when clinical excellence, quality, safety, and innovation come together in one care model. Read more here:

We recently surveyed our customers to learn what quality, safety, and trust really mean to them — and today we’re sharing new data showing how Hims & Hers is raising the bar in telehealth. 🩺 94% say care is as good or better than in-person 📈 91% found the intake process easy;

ICYMI 🎙️ Our very own Dr. Craig Primack sat down with Amanda Bonello, the founder of the GLP-1 Collective, a non-profit organization focused on expanding access to affordable obesity care, to unpack new data from our latest white paper. The data shows that our comprehensive,

Half of California will go through menopause. Zero excuses not to expand access to care. @JShepherd_MD lays it out in @sfchronicle, calling on @CAgovernor to sign bipartisan legislation covering 22 million women. Full piece 👉

Around 100 FDA letters went out last week to companies across the industry as part of the administration’s recent push on pharmaceutical marketing. We got one. A number of big pharma companies received them. With this industry-wide push, the FDA is demonstrating its commitment to

Rotary phone for teen. A few modern tweaks and it works. Finger in hole, turn, click-click back… nostalgia or PTSD? Cord is certainly plotting its tangle.

I would like that today we may together begin to build a culture of reconciliation. We must meet one another, heal our wounds, and forgive the wrongs we did and did not do, but whose effects we still carry. There are no enemies — only brothers and sisters. What we need are

We’re taking on another category. Starting today, @wearehims is in testosterone care with compounded, personalized treatments available on our platform, and more coming in 2026, including an FDA-approved branded oral testosterone through an exclusive health platform collaboration

Thankful to @HHS_Jim and @HHSGov for bringing innovation into the conversation + sitting down with our team. Such a unique opportunity to ensure everyone has access to safe, affordable & appropriate care when/where they need it. It's going to take shaking things up.. but

“Aut enim vis plurium simplicium eadem in rem conferenda est, aut infirmitas alterius alterius virtute sustentanda, aut nimia vis temperanda est lenioribus.“ Aulus Cornelius Celsus’ De Medicina (c. 25 B.C. – 50 A.D.) The sentence quoted comes from Book V, Section 1 where he is

One of the most under appreciated aspects of personalized medicine is often people end up needing meaningfully less medicine to achieve the targeted health benefit.

@ferrisbuhler81 Americans need to know: behind the scenes there’s a war at the FDA. The old regime is working with pharmaceutical companies to ban peptides and restrict access to compounded treatments. Secretary Kennedy drew the line, now it’s on us to stand up and fight for our medical freedom.

We’re thrilled to share some stand-out highlights from our Q2 2025 earnings: ✔️Revenue of $545 million, up 73% YoY ✔️Adjusted EBITDA of $82 million, up 109% YoY ✔️1.5M of our customers are utilizing a personalized treatment plan What’s more, beyond our Q2 earnings, we share a

Strengthen Supply Chains Without Sacrificing Patient Choice ⁦@wearehims⁩ #HealthPolicy #DigitalHealth #PatientAccess #Telehealth

Our own Dr. Craig Primack spoke with @athletechnews about our comprehensive approach to care and the critical role that personalization plays in driving lasting, meaningful outcomes. 📰 Read more: https://t.co/egGU41P1VP #Himsandhers #WeightLoss #Telehealth #HealthInnovation

Exciting News here @wearehims https://t.co/Xr21qeBcGU

We are disappointed to see Novo Nordisk management misleading the public. In recent weeks, Novo Nordisk’s commercial team increasingly pressured us to control clinical standards and steer patients to Wegovy regardless of whether it was clinically best for patients. We refuse to

Happy place

Heartbroken to hear of @GerryConnolly passing. A tireless advocate for Virginia and a truly decent, principled leader. His voice and heart will be deeply missed. Grateful to have known him.